BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 19608025)

  • 1. Myocardial no-reflow in humans.
    Niccoli G; Burzotta F; Galiuto L; Crea F
    J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention and the no-reflow phenomenon.
    van Gaal WJ; Banning AP
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial no-reflow phenomenon: recent knowledges].
    Pontecorvo ML; Spaziani C; Montone RA; Cosentino N; Minelli S; Niccoli G
    Recenti Prog Med; 2011 Feb; 102(2):53-7. PubMed ID: 21513120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
    Monassier JP
    Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular dysfunction following primary percutaneous coronary intervention in the setting of ST-elevation myocardial infarction.
    Ramaraj R; Movahed MR
    J Invasive Cardiol; 2008 Nov; 20(11):603-14. PubMed ID: 18987402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
    Wasilewski J; Osadnik T; Poloński L
    Kardiol Pol; 2006 Sep; 64(9):967-72; discussion 973-4. PubMed ID: 17054028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of the no-reflow phenomenon.
    Vrints CJ
    Acute Card Care; 2009; 11(2):69-76. PubMed ID: 19526383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
    Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
    J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No reflow phenomenon in coronary heart disease.
    Ito H
    J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is Q-wave on admission associated with microvascular injury in patients with acute myocardial infarction treated with primary angioplasty?].
    Dobrzycki S; Korecki J; Kozuch M; Kamiński K; Latocha-Korecka G; Poniatowski B; Filipczuk P; Mazur M; Gorlo A; Musiał WJ
    Przegl Lek; 2004; 61(9):891-4. PubMed ID: 15803893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
    Alfayoumi F; Srinivasan V; Geller M; Gradman A
    Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Dudek D; Sardella G; Marino P; Chevalier B; Zijlstra F
    Eur Heart J; 2008 Dec; 29(24):3002-10. PubMed ID: 18775918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.
    Srinivasan M; Rihal C; Holmes DR; Prasad A
    Circulation; 2009 Mar; 119(9):1311-9. PubMed ID: 19273732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current management of no-reflow].
    Boztosun B; Güneş Y; Kirma C
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):255-60. PubMed ID: 16943112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct stenting after thrombus removal before primary angioplasty in acute myocardial infarction.
    Silva-Orrego P; Bigi R; Colombo P; De Marco F; Oreglia JA; Klugmann S; Gregori D
    J Interv Cardiol; 2008 Aug; 21(4):300-6. PubMed ID: 18754965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.